nach oben

Die Gynäkologie

Erschienen in:

23.08.2019 | Hormonsubstitution | Frauengesundheit in der Praxis

Schilddrüsenerkrankungen in der Peri- und Postmenopause

verfasst von: Dr. med. Antonia Mondorf, Gesine Meyer, Jörg Bojunga

Erschienen in: Die Gynäkologie | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Von der mit fortschreitendem Lebensalter zunehmenden Prävalenz von Schilddrüsenerkrankungen sind Frauen deutlich häufiger betroffen als Männer. Symptome einer Schilddrüsenerkrankung sind oft unspezifisch und damit nicht ohne Weiteres von Symptomen des physiologischen Alterns und auch der Peri‑/Postmenopause abzugrenzen. Eine korrekte Diagnosestellung ist nicht zuletzt im Hinblick auf das in Peri‑/Postmenopause ohnehin erhöhte Osteoporose- und kardiovaskuläre Risiko relevant. Diskutiert werden (Differenzial‑)Diagnostik einschließlich zu berücksichtigender beeinflussender Faktoren sowie Therapie und Therapie-Monitoring auch in besonderen situativen Konstellationen.

Bjoro T et al (2000) Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur J Endocrinol 143:639–647CrossRefPubMed

Faughnan M et al (1995) Screening for thyroid disease at the menopausal clinic. Clin Invest Med 18:11–18PubMed

Bojunga J (2015) Subklinische Schilddrüsenfunktionsstörungen in der Peri- und Postmenopause. J Gynäkol Endokrinol 25:6–11

Hollowell JG et al (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489–499CrossRefPubMed

Mishra GD, Kuh D (2012) Health symptoms during midlife in relation to menopausal transition: British prospective cohort study. BMJ 344:e402CrossRefPubMedPubMedCentral

Stuenkel CA et al (2015) Treatment of symptoms of the menopause: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 100:3975–4011CrossRefPubMed

de los SET, Starich GH, Mazzaferri EL (1989) Sensitivity, specificity, and cost-effectiveness of the sensitive Thyrotropin assay in the diagnosis of thyroid disease in ambulatory patients. Arch Intern Med 149:526CrossRef

Surks MI, Hollowell JG (2007) Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 92:4575–4582CrossRefPubMed

Kratzsch J et al (2005) New reference intervals for thyrotropin and thyroid hormones based on national academy of clinical biochemistry criteria and regular ultrasonography of the thyroid. Clin Chem 51:1480–1486CrossRefPubMed

10.

Chikunguwo S et al (2007) Influence of obesity and surgical weight loss on thyroid hormone levels. Surg Obes Relat Dis 3:631–635 (discussion 635–6)CrossRefPubMed

11.

Bremner AP et al (2012) Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J Clin Endocrinol Metab 97:1554–1562CrossRefPubMed

12.

Surks MI, Boucai L (2010) Age- and race-based serum thyrotropin reference limits. J Clin Endocrinol Metab 95:496–502CrossRefPubMed

13.

Coene KLM (2015) et al. Subclinical hypothyroidism: a ‘laboratory-induced’ condition? Eur J Endocrinol 173:499–505CrossRefPubMed

14.

Li D et al (2017) Association of biotin ingestion with performance of hormone and Nonhormone assays in healthy adults. JAMA 318:1150CrossRefPubMedPubMedCentral

15.

Biscolla RPM, Chiamolera MI, Kanashiro I, Maciel RMB, Vieira JGH (2017) A single 10 mg oral dose of biotin interferes with thyroid function tests. Thyroid 27:1099–1100CrossRefPubMed

16.

Gold EB et al (2013) Factors related to age at natural menopause: longitudinal analyses from SWAN. Am J Epidemiol 178:70–83CrossRefPubMedPubMedCentral

17.

Avis NE et al (2015) Duration of menopausal vasomotor symptoms over the menopause transition. Jama Intern Med 175:531CrossRefPubMedPubMedCentral

18.

Writing Group for the Women’s Health Initiative Investigators (2002) Risks and benefits of estrogen plus Progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trial. J Am Med Assoc 288:321–333CrossRef

19.

Gartlehner G et al (2017) Hormone therapy for the primary prevention of chronic conditions in postmenopausal women. JAMA 318:2234CrossRefPubMed

20.

Techniker Krankenkasse (2018) Gesundheitsreport 2018 Fit oder fertig? Erwerbsbiografien in Deutschland

21.

Manson JE et al (2017) Menopausal hormone therapy and long-term all-cause and cause-specific mortality. JAMA 318:927CrossRefPubMedPubMedCentral

22.

Canaris GJ, Manowitz NR, Mayor G, Ridgway EC (2000) The colorado thyroid disease prevalence study. Arch Intern Med 160:526CrossRefPubMed

23.

Cooper DS, Biondi B (2012) Subclinical thyroid disease. Lancet 379:1142–1154CrossRefPubMed

24.

Gussekloo J et al (2004) Thyroid status, disability and cognitive function, and survival in old age. JAMA 292:2591CrossRefPubMed

25.

Simonsick EM et al (2009) Subclinical hypothyroidism and functional mobility in older adults. Arch Intern Med 169:2011CrossRefPubMedPubMedCentral

26.

Oppo A, Franceschi E, Atzeni F, Taberlet A, Mariotti S (2011) Effects of hyperthyroidism, hypothyroidism, and thyroid autoimmunity on female sexual function. J Endocrinol Invest 34:449–453CrossRefPubMed

27.

Luo H et al (2018) Subclinical hypothyroidism would not lead to female sexual dysfunction in Chinese women. BMC Womens Health 18:26CrossRefPubMedPubMedCentral

28.

Hong H et al (2015) Subclinical hypothyroidism is not a risk factor for female sexual dysfunction in Korean middle-aged women. Thyroid 25:784–788CrossRefPubMed

29.

Atis G et al (2010) Sexual dysfunction in women with clinical hypothyroidism and subclinical hypothyroidism. J Sex Med 7:2583–2590CrossRefPubMed

30.

Biondi B (2007) Cardiovascular effects of mild hypothyroidism. Thyroid 17:625–630CrossRefPubMed

31.

Hyland KA, Arnold AM, Lee JS, Cappola AR (2013) Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study. J Clin Endocrinol Metab 98:533–540CrossRefPubMed

32.

Somwaru LL, Rariy CM, Arnold AM, Cappola AR (2012) The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study. J Clin Endocrinol Metab 97:1962–1969CrossRefPubMedPubMedCentral

33.

Walsh JP et al (2010) Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques. J Clin Endocrinol Metab 95:1095–1104CrossRefPubMed

34.

Stott DJ et al (2017) Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med 376:2534–2544CrossRefPubMed

35.

Meier C et al (2001) TSH-controlled l—Thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel thyroid study). J Clin Endocrinol Metab 86:4860–4866CrossRefPubMed

36.

Feller M et al (2018) Association of thyroid hormone therapy with quality of life and thyroid-related symptoms in patients with subclinical hypothyroidism. JAMA 320:1349CrossRefPubMedPubMedCentral

37.

Korevaar TIM (2018) Randomized, controlled trials show that treatment of subclinical hypothyroidism does not improve quality of life, cognition, blood pressure, or BMI. Clinical Thyroidology 30(11):496–499. https://doi.org/10.1089/ct.2018;30.496-499 CrossRef

38.

Taylor PN et al (2014) Falling threshold for treatment of borderline elevated Thyrotropin levels—balancing benefits and risks. Jama Intern Med 174:32CrossRefPubMed

39.

Mammen JS et al (2015) Thyroid hormone therapy and risk of Thyrotoxicosis in community-resident older adults: findings from the baltimore longitudinal study of aging. Thyroid 25:979–986CrossRefPubMedPubMedCentral

40.

Peeters RP (2017) Subclinical hypothyroidism. N Engl J Med 376:2556–2565CrossRefPubMed

41.

Carlé A, Faber J, Steffensen R, Laurberg P, Nygaard B (2017) Hypothyroid patients encoding combined MCT10 and DIO2 gene Polymorphisms May prefer L‑T3 + L‑T4 combination treatment—data using a blind, randomized, clinical study. Eur Thyroid J 6:143–151CrossRefPubMedPubMedCentral

42.

Wiersinga WM (2017) Therapy of endocrine disease: T4 + T3 combination therapy: is there a true effect? Eur J Endocrinol 177:R287–R296CrossRefPubMed

43.

Arafah BM (2001) Increased need for Thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med 344:1743–1749CrossRefPubMed

44.

Haugen BR (2009) Drugs that suppress TSH or cause central hypothyroidism. Best Pract Res Clin Endocrinol Metab 23:793–800CrossRefPubMedPubMedCentral

45.

Mariotti S et al (1993) Complex alteration of thyroid function in healthy centenarians. J Clin Endocrinol Metab 77:1130–1134PubMed

46.

Haentjens P, Van Meerhaeghe A, Poppe K, Velkeniers B (2008) Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. Eur J Endocrinol 159:329–341CrossRefPubMed

47.

Sawin CT et al (1994) Low serum Thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331:1249–1252CrossRefPubMed

48.

Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA (2001) Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358:861–865CrossRefPubMed

49.

Abe E et al (2003) TSH is a negative regulator of skeletal remodeling. Cell 115:151–162CrossRefPubMed

50.

De Mingo Dominguez ML et al (2018) Low trabecular bone score in postmenopausal women with differentiated thyroid carcinoma after long-term TSH suppressive therapy. Endocrine 62:166–173CrossRefPubMed

51.

Leader A et al (2014) Thyrotropin levels within the lower normal range are associated with an increased risk of hip fractures in euthyroid women, but not men, over the age of 65 years. J Clin Endocrinol Metab 99:2665–2673CrossRefPubMed

52.

Blum MR et al (2015) Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA 313:2055–2065CrossRefPubMedPubMedCentral

53.

Tan ZS et al (2008) Thyroid function and the risk of alzheimer disease<subtitle>the Framingham study</subtitle&gt. Arch Intern Med 168:1514CrossRefPubMedPubMedCentral

54.

Díez JJ (2003) Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management. Gerontology 49:316–323CrossRefPubMed

55.

Schouten BJ, Brownlie BEW, Frampton CM, Turner JG (2011) Subclinical thyrotoxicosis in an outpatient population—predictors of outcome. Clin Endocrinol (oxf) 74:257–261CrossRef

56.

Das G et al (2012) Serum thyrotrophin at baseline predicts the natural course of subclinical hyperthyroidism. Clin Endocrinol (oxf) 77:146–151CrossRef

57.

Bahn RS et al (2011) Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract 17:456–520CrossRefPubMed

58.

Azizi F, Malboosbaf R (2017) Long-term Antithyroid drug treatment: a systematic review and meta-analysis. Thyroid 27:1223–1231CrossRefPubMed

Titel: Schilddrüsenerkrankungen in der Peri- und Postmenopause
verfasst von: Dr. med. Antonia Mondorf
Gesine Meyer
Jörg Bojunga
Publikationsdatum: 23.08.2019
Verlag: Springer Medizin
Schlagwörter: Hormonsubstitution
Erkrankungen der Schilddrüse
Hyperthyreose
Hypothyreose
Osteoporose
Morbus Basedow
Erkrankungen der Schilddrüse
Osteoporose
Levothyroxin
Schilddrüsenhormone
Erschienen in: Die Gynäkologie / Ausgabe 9/2019
Print ISSN: 2731-7102
Elektronische ISSN: 2731-7110
DOI: https://doi.org/10.1007/s00129-019-4490-y

Neu im Fachgebiet Gynäkologie und Geburtshilfe

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Schilddrüsenerkrankungen in der Peri- und Postmenopause

Zusammenfassung

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2019

Das ovarielle Überstimulationssyndrom – Präventionsstrategien und Therapiemanagement

Beckenendlage – Ist die vaginale Geburt out?

Unklare symptomlose retrouterine Raumforderung bei ambulanter Vorsorgeuntersuchung

Do the risks of preimplantation genetic testing for aneuploidy outbalance the benefits?

Die adipöse Patientin mit Kinderwunsch

Geburtshilfliche Risiken nach assistierter Reproduktion

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie